Last edition
News about "nasal drug delivery"
Aptar Pharma Files Patents, Reports Positive Preclinical Data for GLP-1 Nasal and Pulmonary Delivery
Aptar Pharma announced new patent applications and positive preclinical data supporting intranasal and pulmonary GLP-1 delivery, expanding its capabilities in inhaled and intranasal biologic drug delivery.
Nasal Drug Delivery | 29/05/2026 | By News Bureau | 101
European Commission Approves Needle-Free Adrenaline Nasal Spray for Children with Severe Allergies
ALK’s EURneffy 1 mg expands access to needle-free emergency treatment for anaphylaxis in children aged 4 and above across the EU.
Nasal Drug Delivery | 02/04/2026 | By News Bureau
Tiziana Life Sciences Signs Deal for Product Development Services with Renaissance Lakewood
Under this agreement, Renaissance will use its extensive expertise in pharmaceutical-nasal product development and manufacturing to support the production of intranasal foralumab, ensuring compliance with the highest quality and regulatory requirements.
Nasal Drug Delivery | 24/02/2025 | By Aishwarya | 206
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy